Cancer Treatment using Specified Products
Dear Grampian Health Board,
1) In the past 6 months, what was the number of patients treated with a combination of Dabrafenib + Trametinib for the following conditions:
A) Metastatic Melanoma
B) Adjuvant Melanoma
C) BRAF mutated Lung Cancer
2) In the past 6 months, what was the number of patients treated with a combination of Encorafenib (Braftovi) + Binimetnib (Mektovi) for the following conditions:
A) Metastatic Melanoma
B) Colorectal Cancer
Yours faithfully,
BEN HOLDSWORTH
Dear Mr Holdsworth,
Freedom of Information (Scotland) Act 2002
Thank you for your email dated 12 June 2024, requesting information
regarding treatment of cancer with specific pharmaceutical products. We
have recorded this request and are currently processing it in accordance
with the Freedom of Information (Scotland) Act 2002.
A response to your request for information is due by 11 July 2024. Please
allow for delivery time.
We will contact you again in due course.
Best wishes,
Susie
Susie Nattrass
Information Governance Officer
Information Governance Team
NHS Grampian
Rosehill House
Cornhill Road
Aberdeen
AB25 2ZG
Phone: 01224 554983
[1][NHS Grampian request email]
--------------------------------------------------------------------------------------------------------------------------------------------------------
This email is intended for the named recipient only. If you have received
it by mistake,
please (i) contact the sender by email reply; (ii) delete the email from
your system; .
and (iii) do not copy the email or disclose its contents to anyone.
--------------------------------------------------------------------------------------------------------------------------------------------------------
References
Visible links
1. mailto:[NHS Grampian request email]
Dear Mr Holdsworth
Please see attached response to your request.
Regards
Chris
Chris Morrice
Senior Information Governance Officer
NHS Grampian
Rosehill House
ARI
AB25 2ZG
Email: [email address]
--------------------------------------------------------------------------------------------------------------------------------------------------------
This email is intended for the named recipient only. If you have received
it by mistake,
please (i) contact the sender by email reply; (ii) delete the email from
your system; .
and (iii) do not copy the email or disclose its contents to anyone.
--------------------------------------------------------------------------------------------------------------------------------------------------------
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.
Donate Now